#184 - AMA #29: GLP-1 Agonists—The Future of Treating Obesity?
The Peter Attia Drive
In this episode, Rick Doblin, founder and executive director of MAPS, discusses MDMA, a molecule that has (at a minimum) revolutionary therapeutic benefits for PTSD, but arguably could have, at the highest order, a lasting impact on humanity’s...